Rivaroxaban Utilization for Treatment and Prevention of Thromboembolism in Cancer Patients: Experience at a Comprehensive Cancer Center

Clinical trial NCT02502396 · COMPLETED

Trial details

NCT number: NCT02502396
Sponsor: M.D. Anderson Cancer Center
Status: COMPLETED
Study type: OBSERVATIONAL

Cancer Deep-vein Thrombosis of the Lower and Upper Extremities Pulmonary Embolism Non-valvular Atrial Fibrillation

Start date: 2015-09-28
Primary completion: 2022-03-15
Enrollment: 265

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.